메뉴 건너뛰기




Volumn 30, Issue 7, 2007, Pages 746-

Ocular complications of hepatitis C treatment;Complications ophtalmologiques du traitement de l'hépatite C

Author keywords

Hepatitis C; Interferon; Retinopathy; Ribavirin; Visual acuity

Indexed keywords


EID: 34548675610     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(07)91366-2     Document Type: Article
Times cited : (7)

References (20)
  • 1
    • 34548682706 scopus 로고    scopus 로고
    • Conférence de consensus de l'ANAES. Traitement de l'hépatite C. Février 2002.
    • Conférence de consensus de l'ANAES. Traitement de l'hépatite C. Février 2002.
  • 2
    • 0034324083 scopus 로고    scopus 로고
    • Pegylated interferon alfa-2b: Pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data
    • Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, et al. Pegylated interferon alfa-2b: pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data. Clin Pharmacol Ther, 2000;68:556-67.
    • (2000) Clin Pharmacol Ther , vol.68 , pp. 556-567
    • Glue, P.1    Fang, J.W.2    Rouzier-Panis, R.3    Raffanel, C.4    Sabo, R.5    Gupta, S.K.6
  • 3
    • 0036830454 scopus 로고    scopus 로고
    • Side effects of therapy of hepatitis C and their management
    • Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology, 2002;36:237-4.
    • (2002) Hepatology , vol.36 , pp. 237-234
    • Fried, M.W.1
  • 4
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP, Mc Hutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 2001;358:958-65.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    Mc Hutchinson, J.G.2    Gordon, S.C.3    Rustgi, V.K.4    Shiffman, M.5    Reindollar, R.6
  • 6
    • 0642314315 scopus 로고    scopus 로고
    • Management of newly diagnosed hepatitis C virus infection
    • Russo MW, Zacks SL, Fried MW. Management of newly diagnosed hepatitis C virus infection. Cleve Clin J Med, 2003;70(Suppl 4):14-20.
    • (2003) Cleve Clin J Med , vol.70 , Issue.SUPPL. 4 , pp. 14-20
    • Russo, M.W.1    Zacks, S.L.2    Fried, M.W.3
  • 7
    • 23444460553 scopus 로고    scopus 로고
    • Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin
    • Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Goncales FL Jr, et al. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin. J Hepatol, 2005;43:425-33.
    • (2005) J Hepatol , vol.43 , pp. 425-433
    • Ferenci, P.1    Fried, M.W.2    Shiffman, M.L.3    Smith, C.I.4    Marinos, G.5    Goncales Jr, F.L.6
  • 8
    • 1442282967 scopus 로고    scopus 로고
    • Guidelines for stopping therapy in chronic hepatitis C
    • Russo MW, Fried MW. Guidelines for stopping therapy in chronic hepatitis C. Curr Gastroenterol Rep, 2004;6:17-21.
    • (2004) Curr Gastroenterol Rep , vol.6 , pp. 17-21
    • Russo, M.W.1    Fried, M.W.2
  • 9
    • 0028323634 scopus 로고
    • Acute onset of ocular complications with interferon
    • Yamada H, Mizobuchi K, Isogai Y. Acute onset of ocular complications with interferon. Lancet, 1994;343:914.
    • (1994) Lancet , vol.343 , pp. 914
    • Yamada, H.1    Mizobuchi, K.2    Isogai, Y.3
  • 10
    • 4143101297 scopus 로고    scopus 로고
    • Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection
    • Willson RA. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection. J Clin Gastroenterol, 2004;38:717-22.
    • (2004) J Clin Gastroenterol , vol.38 , pp. 717-722
    • Willson, R.A.1
  • 11
    • 0038282524 scopus 로고    scopus 로고
    • Interferon-associated retinopathy
    • Savant V, Gillow T. Interferon-associated retinopathy. Eye, 2003;17:534-6.
    • (2003) Eye , vol.17 , pp. 534-536
    • Savant, V.1    Gillow, T.2
  • 12
    • 33745447903 scopus 로고    scopus 로고
    • Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C
    • Okuse C, Yotsuyanagi H, Nagase Y, Kobayashi Y, Yasuda K, Koike K, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol, 2006;12:3756-9.
    • (2006) World J Gastroenterol , vol.12 , pp. 3756-3759
    • Okuse, C.1    Yotsuyanagi, H.2    Nagase, Y.3    Kobayashi, Y.4    Yasuda, K.5    Koike, K.6
  • 13
    • 9644258505 scopus 로고    scopus 로고
    • Is screening for interferon retinopathy in hepatitis C justified?
    • Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol, 2004;88:1518-20.
    • (2004) Br J Ophthalmol , vol.88 , pp. 1518-1520
    • Cuthbertson, F.M.1    Davies, M.2    McKibbin, M.3
  • 14
    • 4444248245 scopus 로고    scopus 로고
    • Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin
    • Farel C, Suzman DL, McLaughlin M, Campbell C, Koratich C, Masur H et al. Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin. AIDS, 2004;18:1805-9.
    • (2004) AIDS , vol.18 , pp. 1805-1809
    • Farel, C.1    Suzman, D.L.2    McLaughlin, M.3    Campbell, C.4    Koratich, C.5    Masur, H.6
  • 15
    • 0000310101 scopus 로고
    • Prospective study of the incidence of interferon-induced retinopathy in patients with chronic hepatitis
    • Nao-i N, Matuura Y, Sawada A. Prospective study of the incidence of interferon-induced retinopathy in patients with chronic hepatitis. Ophtalmology, 1994;101(Suppl):119.
    • (1994) Ophtalmology , vol.101 , Issue.SUPPL. , pp. 119
    • Nao-i, N.1    Matuura, Y.2    Sawada, A.3
  • 16
    • 20444501429 scopus 로고    scopus 로고
    • Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C
    • Yaghi C, Baz P, Koussa S, Daniel F, Haddad F, Sayegh R. Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C. Gastroenterol Clin Biol, 2005;29:616-7.
    • (2005) Gastroenterol Clin Biol , vol.29 , pp. 616-617
    • Yaghi, C.1    Baz, P.2    Koussa, S.3    Daniel, F.4    Haddad, F.5    Sayegh, R.6
  • 17
    • 6344282654 scopus 로고    scopus 로고
    • Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin
    • Kirchhoff A, Kirchhoff U, Lafrenz M, Guthoff R. Bilateral AION after the combined therapy of hepatitis C with PEG-interferon alpha2B and ribavirin. Klin Monatsbl Augenheilkd, 2004;221:791-3.
    • (2004) Klin Monatsbl Augenheilkd , vol.221 , pp. 791-793
    • Kirchhoff, A.1    Kirchhoff, U.2    Lafrenz, M.3    Guthoff, R.4
  • 19
    • 16344382588 scopus 로고    scopus 로고
    • Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: A multifocal electroretinogram investigation
    • Chisholm JA, Williams G, Spence E, Sparks S, Keating D, Gavin M et al. Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation. Aliment Pharmacol Ther, 2005;21:723-32.
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 723-732
    • Chisholm, J.A.1    Williams, G.2    Spence, E.3    Sparks, S.4    Keating, D.5    Gavin, M.6
  • 20
    • 1842459212 scopus 로고    scopus 로고
    • Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: A case report
    • Crochet M, Ingster-Moati I, Even G, Dupuy P. Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report. J Fr Ophtalmol, 2004;27:257-62.
    • (2004) J Fr Ophtalmol , vol.27 , pp. 257-262
    • Crochet, M.1    Ingster-Moati, I.2    Even, G.3    Dupuy, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.